News & Perspective

Mar 30, 2006

Mar 30, 2006

H5N1 vaccine trial shows limited benefit

(CIDRAP News) – The first experimental US vaccine for H5N1 avian influenza yielded only modest results in its first clinical trial, generating an adequate immune response in slightly more than half of participants who received a heavy dose, scientists report.

Mar 22, 2006

Mar 22, 2006

WHO issues revised plan to douse pandemic spark

(CIDRAP News) – The World Health Organization (WHO) has published a new draft of its plan for spotting and stopping a budding influenza pandemic.

Mar 07, 2006

Mar 07, 2006

HHS using Indonesian strain for second H5N1 flu vaccine

(CIDRAP News) – A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.

In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.

Mar 02, 2006

Mar 02, 2006

China may have more avian flu this spring, leader warns

(CIDRAP News) – China's vice premier said today that China may see more bird outbreaks and human cases of avian influenza this spring, as the government announced plans for an intensive hunt for cases among wild birds on a major migration route, according to news services.

Feb 27, 2006

Feb 27, 2006

Survey: Most Americans concerned about avian flu

(CIDRAP News) – More than half of Americans are concerned about the threat of avian influenza reaching the United States, but few are "very concerned" and fewer still have looked into getting an antiviral drug to protect themselves, according to a survey from the Harvard School of Public Health (HSPH).

Feb 17, 2006

Feb 17, 2006

2006 SUMMIT COVERAGE: Businesses zero in on details of pandemic flu planning

(CIDRAP News) – Critical for businesses in preparing for a flu pandemic will be taking care of their primary asset—their employees. This was an overarching theme expressed by participants in this week's Business Planning for Pandemic Influenza: A National Summit, held in Minneapolis.

Feb 15, 2006

Feb 15, 2006

2006 SUMMIT COVERAGE: Conference poll: 18% of businesses have pandemic plan

(CIDRAP News) – A large majority of about 300 business officials at a conference in Minneapolis believe that an influenza pandemic would significantly affect their business, but only 18% of the companies have completed a preparedness plan, according to a poll taken yesterday.

Feb 15, 2006

2006 SUMMIT COVERAGE: Pandemic could cripple routine health services

Editor's Note: This article was updated Aug 16, 2006, to correct a potentially misleading statement in the 3rd-to-last paragraph regarding Seattle residents' concerns.

(CIDRAP News) – A major influenza pandemic would make it very difficult for the US healthcare system to maintain routine services, a reality that few Americans are aware of, a public health official said at a preparedness conference in Minneapolis today.

Feb 15, 2006

2006 SUMMIT COVERAGE: How will the infrastructure fare in a flu pandemic?

(CIDRAP News) – Putting an additional stressor, such as a flu pandemic, on an infrastructure that is already stressed and running at a stretched capacity merits great concern, said experts convening yesterday at a national summit on business planning for pandemic influenza in Minneapolis.

Feb 14, 2006

Feb 14, 2006

2006 SUMMIT COVERAGE: Business leaders urged to plan for severe flu pandemic

(CIDRAP News) – Speakers at a national conference in Minneapolis today sought to impress business leaders with the potentially disastrous effects of an influenza pandemic without scaring them into thinking that preparing for one is futile.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»